Development of a patient decision aid on inhaled corticosteroids use for adults with asthma.

J Asthma

a Knowledge Translation , Education and Prevention Chair in Respiratory and Cardiovascular Health, Laval University, Quebec City , Quebec , Canada.

Published: November 2016

AI Article Synopsis

  • Patient decision aids (PDAs) are tools designed to enhance communication between healthcare practitioners and patients, helping individuals with asthma make informed choices about inhaled corticosteroids and other treatment options.
  • The development of the PDA involved drafting, iterative testing for acceptability with certified asthma educators (CAEs) and adult patients, and refining it based on feedback until no further suggestions were needed.
  • The final product is a 12-page, color-printed booklet that was deemed acceptable and usable by the target audience, indicating its effectiveness in supporting asthma management decisions.

Article Abstract

Background: Patient decision aids (PDAs) are used in shared decision making to improve practitioner-patient communication and help patients decide about treatment options. To develop a PDA for adults with asthma considering inhaled corticosteroids, with or without long-acting beta2-agonists, to optimize asthma control.

Methods: The PDA was developed based on the International Patient Decision Aid Standards. Step 1: PDA was drafted. Step 2: PDA acceptability was assessed among target users, certified asthma educators (CAEs) and adults with asthma, following an iterative process. a) Participants read the PDA, b) rated its presentation, length, balance, and perceived usefulness, indicated what they liked/disliked about it, and made suggestions for improvement. c) Based on results from (b), PDA was refined. This process was repeated with new participants until no suggestions were made. Step 3: The PDA was field tested with target users. Interviews with CAEs were conducted to identify areas of improvement. Step 4: Final PDA version was written.

Results: A color-printed, 4-page, letter-sized PDA was drafted. Acceptability testing involved 11 CAEs (women, n = 10) and 20 adults with asthma (women, n = 13; age 22-61 years). Five successive refined versions were produced. Major changes were made to PDA terminology, instructions, paper size, and visual presentation. Two CAEs (women, n = 2) and 26 adults with asthma (women, n = 19; age 20-65 years) field tested PDA. Minor changes were made to language and instructions to ensure usability. The final version was a color-printed, 12-page, A3-sized booklet.

Conclusion: Our newly developed PDA was found acceptable and usable in target users.

Download full-text PDF

Source
http://dx.doi.org/10.3109/02770903.2016.1166384DOI Listing

Publication Analysis

Top Keywords

adults asthma
20
patient decision
12
pda
12
step pda
12
target users
12
decision aid
8
inhaled corticosteroids
8
pda drafted
8
field tested
8
caes women
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!